Liposomal Bupivacaine for Pain Relief in Microvascular Decompression Surgery

This study is focused on improving pain management for patients who have undergone microvascular decompression surgery, a type of brain surgery. Many patients experience significant pain after such procedures, especially within the first two days. Traditional methods often use strong painkillers that can have unwanted side effects. This research is exploring the use of a new local anesthetic called liposomal bupivacaine, which is applied directly at the incision site. The goal is to see if this method can better manage pain by releasing the medication slowly over three days, potentially reducing the need for other pain medications and their side effects. Participants in this study are divided into two groups. One group receives liposomal bupivacaine directly at the incision site before the surgery starts, while the other group follows the usual practice without this local application. Researchers then track how effective the pain relief is by measuring the pain levels at rest over the first 72 hours after surgery. They also monitor when patients first ask for additional pain relief, the amount of rescue pain medication needed, and other health indicators like heart rate and blood pressure during and after the surgery. Additionally, the study examines the overall recovery experience and the length and cost of the hospital stay to see if this new method provides significant benefits.